KTN's online platform helps you to make the connections you need


The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.


The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

« go back

New Chief Executive Officer of the Precision Medicine Catapult

The Precision Medicine Catapult, the UK's innovation centre for precision medicine, announces it has appointed Dr Belinda Quinn as its new Chief Executive Officer.

Belinda has been working as Chief Clinical Officer of the Precision Medicine Catapult over the past six months, formulating and landscaping Precision Medicine opportunities across the UK. She has played a pivotal leadership role in mobilising the seven Centres of Excellence integral to the success of the Precision Medicine Catapult.

Belinda trained as a doctor specialising in neurology before diversifying into IT and clinical leadership roles. She has held executive and transformational change roles across the public and private sector including big pharma, global management consulting, the NHS, data and regulatory in the UK, Australia and the Middle East.

Richard Barker, Chairman of the Precision Medicine Catapult said: "Belinda brings deep experience and great energy to the task of building the Precision Medicine Catapult and delivering its strategy. With our ambition to create value for the NHS, private sector companies and most importantly for patients through the development of precision medicine, her ability to bring together all these interests will be invaluable."

Ruth McKernan, Chief Executive of Innovate UK, the Precision Medicine Catapult primary funder, said: "The Precision Medicine Catapult will transform the UK’s capability for innovation in this important sector, helping to drive economic growth and deliver significant improvements in health. Belinda has already built a strong reputation with colleagues across the UK and I am confident that the Catapult will be a powerful force in making the UK a leader in precision medicine.”

Belinda Quinn said: “I am delighted to accept the role as CEO of the Precision Medicine Catapult and will continue to build on the momentum and progress we have made in the last year. I am excited by the opportunity to work with the many world-leading experts in research and clinical practice that we have in this country, coupled with industry partners and Innovate UK to help bring forward innovative, sustainable and more cost-effective solutions that will build the UK’s precision medicine industry, benefit patients and improve the effectiveness and efficiency of the healthcare system in the UK.”